Article Information
History
- May 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Christopher A. Rice1,2,*,
- Beatrice L. Colon2,3,#,
- Emily Chen4,
- Mitchell V. Hull4 and
- Dennis E. Kyle1,2,3,*
- 1Department of Cellular Biology, University of Georgia, Athens, Georgia, USA
- 2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA, 30602
- 3Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA
- 4Calibr at Scripps Research, La Jolla, CA, USA, 92037
- ↵*Corresponding authors Email: dennis.kyle{at}uga.edu (DEK); christopher.rice{at}uga.edu (CAR).
Posted May 13, 2020.
Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae
